Perrigo Company plc

NYSE: PRGO
$31.94
+$0.67 (+2.1%)
Closing price April 26, 2024
Perrigo Company plc is a global leader in over-the-counter health and wellness products, enhancing individual well-being with a broad range of consumer self-care items. From cough suppressants and allergy relief to infant formulas, digestive aids, and pain relievers, Perrigo develops, manufactures, and markets products that address a wide spectrum of everyday health concerns. Its portfolio also includes skin care, women’s health, vitamins, and smoking cessation products, sold under well-known brands like Nasonex, Prevacid24HR, and Nicorette. With a history dating back to 1887, Perrigo serves customers worldwide through pharmacies, supermarkets, and online stores, headquartered in Dublin, Ireland.
Teva Pharmaceutical Industries has just approached Mylan with a public takeover bid valued at $82 per share in cash and stock.
Independent research firm Argus has weighed in on Mylan and Perrigo prior to the acquisition.
Friday's top analyst upgrades, downgrades and initiations include Apple, Citrix Systems, Kythera Biopharmaceuticals, Mylan, Netflix and Weatherford International.
Generic drug maker Mylan has proposed to acquire rival Perrigo for $205 per share in cash and stock.
A new research report from the technical team at RBC cites Bristol-Myers Squibb, Eli Lilly, Mylan and Perrigo as stocks that may continue to show sector leadership.
24/7 Wall St. has compiled a list health care stocks that Merrill Lynch expects to be top performers in 2015.
A new research report from Merrill Lynch features three top pharmaceutical companies, dubbed the “Irish 3-Pack.”
Source: Wikimedia CommonsWith the U.S. pharmaceutical group, and particularly the specialty pharmaceutical names, under pressure over recent trading sessions, the large biotechnology stocks were not...
St. Patrick's Day may have come and gone for this year, but the analysts at biotech boutique shop Leerink have highlighted six Ireland-based firms that could be tempting takeover targets for large...
These are the top analyst upgrades, downgrades and initiations seen from Wall Street research firms on Tuesday, February 11, 2014. They include Alcatel-Lucent, CenturyLink, Cisco Systems , FireEye...
Stocks are at all-time highs again, and investors have to be wondering which stocks and sectors they should be holding, buying and selling. 24/7 Wall St. looks each morning for top research ideas...
Source: ThinkstockMerck & Co. Inc. (NYSE: MRK) is seeing one more drug drive off the patent cliff. News was released on Monday by Teva Pharmaceutical Industries Ltd. (NYSE: TEVA) that it and...
Source: ThinkstockThe 2012 to 2013 flu season has reached what is officially at pandemic levels. The government report last week showed that more than 7% of the deaths in the prior week were tied to...
These are some of Thursday’s top analyst upgrades, downgrades, and initiations seen from Wall Street research calls.Autodesk Inc. (NASDAQ: ADSK) Raised to Buy with $47 target at Argus. Carnival...
These are some of this Monday’s top analyst research summaries of upgrades and downgrades from Wall Street firms: ARM Holdings plc (NASDAQ: ARMH) Cut to Sell at Benchmark. ADC...